More on ETON

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+400.0% Growth)
- Ratings (10.0 Score)
- FDA

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eton Pharmaceuticals Inc. (NQ:ETON)
Delayed: 31.59 -0.52 (1.62%)
Prev. Close $32.11  
Open$32.12 
52 Wk High$ 
52 Wk Low$ 
Day High$32.78 
Day Low$31.27 
P/E N/A  
EPS$ 
Volume206,786 


Jun 9, 2026 04:31 PM Form 8-K Eton Pharmaceuticals, For: Jun 09
Jun 2, 2026 04:49 PM Form 144 Eton Pharmaceuticals, Filed by: Gruber James R.
Jun 1, 2026 04:27 PM Form 3 Eton Pharmaceuticals, For: Jun 01 Filed by: Matthews Judith M.
May 29, 2026 04:17 PM Form 4 Eton Pharmaceuticals, For: May 28 Filed by: BRYNJELSEN SEAN
May 28, 2026 03:12 PM Form 144 Eton Pharmaceuticals, Filed by: BRYNJELSEN SEAN
May 27, 2026 06:29 PM Form 4 Eton Pharmaceuticals, For: May 22 Filed by: Krempa David
May 22, 2026 04:25 PM Form 144 Eton Pharmaceuticals, Filed by: Krempa David
May 21, 2026 06:40 AM H.C. Wainwright Reiterates Buy Rating on Eton Pharmaceuticals (ETON)
May 19, 2026 04:45 PM Form 8-K Eton Pharmaceuticals, For: May 18
May 19, 2026 04:30 PM Eton Pharmaceuticals acquires US rights to rare disease drug IMPAVIDO
View All Articles

Entities mentioned with ETON

View All Entities